Christoph Goos

发表

Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Circulation.

Death within 44 days of 2,4-dinitrophenol intake

D. Rentsch, A. Büttner, Christoph Goos, 2016, International Journal of Legal Medicine.

A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, Journal of the American College of Cardiology.